{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:15:36Z","timestamp":1783707336838,"version":"3.55.0"},"reference-count":19,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Study Type \u2013 Therapy (RCT)\u2028Level of Evidence\u20031b<\/jats:p>\n                    <jats:p>\n                      <jats:bold>What\u2019s known on the subject? and What does the study add?<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>Several authors have reported their experience with PDE5 inhibitors alone or in combination with selective serotonin re\u2010uptake inhibitors for treating premature ejaculation. However, to our knowledge, this is the first laboratory design study to evaluate the effects of three PDE5 inhibitors throughout the ejaculation process in men with lifelong premature ejaculation. In this laboratory setting study PDE5 inhibitors seem to prolong ELT but the difference from placebo is significant only in vardenafil. The quality of penile rigidity is better with PDE5 inhibitors in the post\u2010ejaculatory period but the difference is significant only in sildenafil and vardenafil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\u2022\u2002To evaluate the effects of three phosphodiesterase type 5 (PDE5) inhibitors on the ejaculation process in men with lifelong premature ejaculation using a double\u2010blind laboratory setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>\u2022\u2002Eighty men with lifelong premature ejaculation, 20 in each group, received placebo, vardenafil (10\u00a0mg), sildenafil (50\u00a0mg) or tadalafil (20\u00a0mg) in a double\u2010blind study design. Placebo or PDE5 inhibitor was ingested after at least 2\u00a0h fasting and non\u2010smoking. The subjects were placed in a silent room immediately and real\u2010time penile rigidity and tumescence was monitored.<\/jats:p>\n                    <jats:p>\u2022\u2002Subjects read some magazines or newspapers without any sexually stimulating material for 1.5\u00a0h. At the end of this period audiovisual sexual stimulation began with a video film and after the 8th minute the subject began vibratory stimulation to the frenular area.<\/jats:p>\n                    <jats:p>\u2022\u2002At the beginning of ejaculation the patient stopped stimulation. When the patient began and stopped stimulation, the light near the observer turned on and off and the observer calculated the ejaculation period with a chronometer. The elapsed time was the ejaculation latency time (ELT) in seconds.<\/jats:p>\n                    <jats:p>\u2022\u2002There was no interaction between subjects and observer during the test. The ELT, and the qualities of base and tip rigidities during ELT and after ejaculation were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      \u2022\u2002Median age of patients was 29 (range 22\u201339) years and median duration of premature ejaculation was 60 (range 7\u2013180) months and there was no significant difference between groups. Median duration of vibratory stimulation (ELT) of subjects who received placebo was 48.5\u00a0s: 53.5\u00a0s for sildenafil, 70.0\u00a0s for tadalafil and 82.5\u00a0s for vardenafil. Compared with the placebo group, ELT was significantly longer only in subjects receiving vardenafil (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.019).\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022\u2002In the post\u2010ejaculatory refractory period, times to last recorded base rigidities were significantly longer than placebo in vardenafil and sildenafil groups with better erection quality (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.01 for each).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\u2022\u2002The PDE5 inhibitors seem to prolong ELT and the quality of penile rigidity is better with PDE5 inhibitors in post\u2010ejaculatory period.<\/jats:p>\n                    <jats:p>\u2022\u2002These findings suggest that PDE5 inhibitors might have some beneficial effects in men with lifelong premature ejaculation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2010.09646.x","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T21:42:06Z","timestamp":1283895726000},"page":"1274-1277","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double\u2010blind laboratory setting study"],"prefix":"10.1111","volume":"107","author":[{"given":"Ahmet","family":"G\u00f6k\u00e7e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikret","family":"Halis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Demirtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Ekmekcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2004.08.023"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2005.00593.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/00926239308404371"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07755.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07719.x"},{"key":"e_1_2_7_8_2","article-title":"The effects of phosphodresterase type 5\/variables during a period with no inhibitors on penile rigidity sexual stimulation: a laboratory setting double\u2010blind study","author":"G\u00f6k\u00e7e A","year":"2010","journal-title":"BJU Int"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.07.020"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06290.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2009.21"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0272.2008.00910.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-010-9710-2"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000112607"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900630"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.09.012"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901005"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.9.1377"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00443_2.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01542027"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2010.09646.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2010.09646.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:01:20Z","timestamp":1761753680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2010.09646.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1464-410X.2010.09646.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2010.09646.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]},"assertion":[{"value":"2010-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}